PHD fingers epigenetic effectors and potential drug targets

Molecular Interventions

Volumn 9, Issue 6, 2009, Pages 314-323

  Musselman, Catherine A ^a   Kutateladze, Tatiana G ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; DNA METHYLTRANSFERASE 3A; HISTONE; HOMEODOMAIN PROTEIN; PLANT HOMEODOMAIN FINGER PROTEIN; RAG2 PROTEIN; UNCLASSIFIED DRUG; VEGETABLE PROTEIN; ZINC FINGER PROTEIN;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENETICS; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; HISTONE CODE; HUMAN; IMMUNE DEFICIENCY; MENTAL DEFICIENCY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NEOPLASM; NONHUMAN; PROTEIN BINDING; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; TRANSCRIPTION INITIATION; ZINC FINGER MOTIF;

EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC DISEASES, INBORN; HUMANS; PROTEINS;

EID: 75749129110     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.9.6.7     Document Type: Review

References (76)

1. Schindler, U., Beckmann, H., Cashmore, A.R., and Schindler, T.F. HAT3.1, a novel Arabidopsis homeodomain protein containing a conserved cysteine-rich region. Plant J. 4, 137-150 (1993).
2. Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F., and Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. [see comment]. Nature 389, 251-260 (1997).
3. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007).
4. Taverna, S.D., Li, H., Ruthenburg, A.J., Allis, C.D., and Patel, D.J. How chromatin-binding modules interpret histone modifications: Lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 14, 1025-1040 (2007
5. Berger, S.L. The complex language of chromatin regulation during transcription. Nature 447, 407-412 (2007).
6. Strahl, B.D. and Allis, C.D. The language of covalent histone modifications. Nature 403, 41-45 (2000).
7. Jenuwein ,T. and Allis, C.D. Translating the histone code. Science 293, 1074-1080 (2001).
8. Ruthenburg, A.J., Allis, C.D., and Wysocka, J. Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark. Mol. Cell 25, 15-30 (2007).
9. Ruthenburg, A.J., Li, H., Patel, D.J., Allis, C.D. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol. Cell Biol 8, 983-994 (2007).
10. Shi, X., Kachirskaia, I., Walter, K.L. et al. Proteome-wide analysis in Saccharomyces cerevisiae identifies several PHD fingers as novel direct and selective binding modules of histone H3 methylated at either lysine 4 or lysine 36. J. Biol. Chem. 282, 2450-2455 (2007).
11. Li, H., Ilin, S., Wang, W., Duncan, E.M., Wysocka, J., Allis, C.D., and Patel, D.J. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442, 91-95 (2006).
12. Peña, P.V., Davrazou, F., Shi, X., Walter, K.L., Verkhusha, V.V., Gozani, O., Zhao, R., and Kutateladze, T.G. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 442, 100-103 (2006).
13. Shi X, Hong, T. Walter, K.L. et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442, 96-99 (2006).
14. Wysocka. J., Swigut, T., Xiao, H. et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442, 86-90 (2006).
15. Soliman, M.A. and Riabowol, K. After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem. Sci. 32, 509-519 (2007).
16. Skowyra, D., Zeremski, M., Neznanov, N. et al. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J. Biol. Chem. 276, 8734-8739 (2001).
17. Kuzmichev, A., Zhang, Y., Erdjument-Bromage, H., Tempst, P., and Reinberg, D. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). Mol. Cell Biol 22, 835-848 (2002).
18. Doyon, Y. Cayrou, C., Ullah, M. et al. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol. Cell 21, 51-64 (2006).
19. Peña, P.V., Hom, R.A., Hung, T. et al. Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor. J. Mol. Biol. 380, 303-312 (2008).
20. Doyon, Y., Selleck, W., Lane, W.S., Tan, S., and Cote, J. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol. Cell Biol 24, 1884-1896 (2004).
21. Hung, T., Binda, O., Champagne, K.S., Kuo, A.J., Johnson, K., Chang, H.Y., Simon, M.D., Kutateladze, T.G., and Gozani, O. ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation. Mol. Cell 33, 248-256 (2009).
22. Saksouk, N., Awakumov, N., Champagne, K.S. et al. HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail. Mol. Cell 33, 257-265 (2009).
23. Champagne, K.S., Saksouk, N., Peña, P.V., Johnson, K., Ullah, M., Yang, X.J., Côté, J., and Kutateladze, T.G. The crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide. Proteins 72, 1371-1376 (2008).
24. Wang, G.G., Song, J., Wang, Z., Dormann, H.L., Casadio, F., Li, H., Luo, J.L., Patel, D.J., and Allis, C.D. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 459, 847-851 (2009).
25. Fiedler, M., Sánchez-Barrena, M.J., Nekrasov, M., Mieszczanek, J., Rybin, V., Müller, J., Evans, P., and Bienz, M. Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. Mol. Cell 30, 507-518 (2008).
26. Liu, Y., Subrahmanyam, R., Chakraborty, T., Sen, R., and Desiderio, S. A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity 27, 561-571 (2007).
27. Matthews AG, Kuo, A.J. Ramon-Manques S. et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D).J recombination. Nature 450, 1106-1110 (2007).
28. Ramón-Maiques, S., Kuo, A.J., Carney, D., Matthews, A.G., Oettinger, M.A., Gozani, O., and Yang, W. The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc. Natl. Acad. Sci. USA 104, 18993-18998 (2007).
29. Vermeulen, M., Mulder, K.W., Denissov, S. et al. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 131, 58-69 (2007).
30. van Ingen, H., van Schaik, F.M., Wienk, H. et al. Structural insight into the recognition of the H3K4me3 mark by the TFIID subunit TAF3. Structure 16, 1245-1256 (2008).
31. Lan, F., Collins, R.E., De Cegli, R., Alpatov, R., Horton, J.R., Shi, X., Gozani, O., Cheng, X., Shi, Y. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 448, 718-722 (2007).
32. Ooi, S.K., Qiu, C., Bernstein, E. et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448, 714-717 (2007).
33. Otani, J., Nankumo, T., Arita, K., Inamoto, S., Ariyoshi, M., and Shirakawa, M. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep. 10, 1235-1241 (2009).
34. Org, T., Chignola, F., Hetényi, C. et al. The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep. 9, 370-376 (2008).
35. Koh, A.S., Kuo, A.J., Park, S.Y. Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity. Proc. Natl. Acad. Sci. USA 105, 15878-15883 (2008).
36. Musselman, C.A., Mansfield, R.E., Garske, A.L. et al. Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications. Biochem. J. 423, 179-187 (2009).
37. Zegerman, P., Canas, B., Pappin, D., and Kouzarides, T. Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD). repressor complex. J. Biol. Chem. 277, 11621-11624 (2002).
38. Zhou, M.I., Foy, R.L., Chitalia, V.C., Zhao, J., Panchenko, M.V., Wang, H., Cohen, H.T. Jade-1, a candidate renal tumor suppressor that promotes apoptosis. Proc. Natl. Acad. Sci. USA 102, 11035-11040 (2005).
39. Iwase, S., Lan, F., Bayliss, P. et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077-1088 (2007).
40. Karagianni, P., Amazit, L., Qin, J., and Wong, J. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol. Cell Biol 28, 705-717 (2008).
41. Jensen, L.R., Amende, M., Gurok, U. et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76, 227-236 (2005).
42. Papait, R., Pistore, C., Grazini, U. et al. The PHD domain of Np95 (mUHRF1). is involved in large-scale reorganization of pericentromeric heterochromatin. Mol. Biol. Cell 19, 3554-3563 (2008).
43. Arita, K., Ariyoshi, M., Tochio, H., Nakamura, Y., and Shirakawa, M. Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 455, 818-821 (2008).
44. Lange M, Kaynak, B., Forster, U.B. et al. Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex. Genes Dev. 22, 2370-2384 (2008).
45. Palacios, A., Muñoz, I.G., Pantoja-Uceda, D., Marcaida, M.J., Torres, D., Martín-García, J.M., Luque, I., Montoya, G., and Blanco, F.J. Molecular basis of histone H3K4me3 recognition by ING4. J. Biol. Chem. 283, 15956-15964 (2008).
46. Jacobs, S.A. and Khorasanizadeh, S. Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science 295, 2080-2083 (2002).
47. Nielsen, P.R., Nietlispach, D., Mott, H.R., Callaghan, J., Bannister, A., Kouzarides, T., Murzin, A.G., Murzina, N.V., and Laue, E.D. Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9. Nature 416, 103-107 (2002).
48. Fischle, W., Wang, Y., Jacobs, S.A., Kim, Y., Allis, C.D., and Khorasanizadeh, S. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev. 17, 1870-1881 (2003).
49. Huang, Y., Fang, J., Bedford, M.T., Zhang, Y., and Xu, R.M. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science 312, 748-751 (2006).
50. Botuyan, M.V., Lee, J., Ward, I.M., Kim, J.E., Thompson, J.R., Chen, J., and Mer, G. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 127, 1361-1373 (2006).
51. Li, H., Fischle, W., Wang, W., Duncan, E.M., Liang, L., Murakami-Ishibe, S., Allis, C.D. and Patel, D.J. Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger. Mol. Cell 28, 677-691 (2007).
52. Min, J. L3MBTL1 recognition of mono- and dimethylated histones. Nat. Struct. Mol. Biol. 14, 1229-1230 (2007).
53. Chignola, F. The solution structure of the first PHD finger of autoimmune regulator in complex with non-modified histone H3 tail reveals the antagonistic role of H3R2 methylation. Nucleic Acids Res. 37, 2951-2961 (2009).
54. Chakravarty, S., Zeng, L., and Zhou, M.M. Structure and site-specific recognition of histone H3 by the PHD finger of human autoimmune regulator. Structure 17, 670-679 (2009).
55. Guccione, E. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 449, 933-937 (2007).
56. Kirmizis, A. Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 449, 928-932 (2007).
57. Kirmizis, A. Distinct transcriptional outputs associated with mono- and dimethylated histone H3 arginine 2. Nat. Struct. Mol. Biol. 16, 449-451 (2009).
58. Baker, L.A., Allis, C.D., Wang, G.G. PHD fingers in human diseases: Disorders arising from misinterpreting epigenetic marks. Mutat. Res. 647, 3-12 (2008).
59. Ishii, T., Suzuki, Y., Ando, N., Matsuo, N., and Ogata, T. Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 85, 2922-2926 (2000).
60. Bjorses, P. Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy protein. Am. J. Hum. Genet. 66, 378-392 (2000).
61. Stolarski, B. Molecular background of polyendocrinopathy-candidiasis- ectodermal dystrophy syndrome in a Polish population: Novel AIRE mutations and an estimate of disease prevalence. Clin. Genet. 70, 348-354 (2006).
62. Saugier-Veber, P. Identification of a novel mutation in the autoimmune regulator (AIRE-1). gene in a French family with autoimmune polyen-docrinopathy- candidiasis-ectodermal dystrophy. Eur. J. Endocrinol. 144, 347-351 (2001).
63. Campos, E.I., Chin, M.Y., Kuo, W.H., and Li, G. Biological functions of the ING family tumor suppressors. Cell Mol. Life Sci. 61, 2597-2613 (2004).
64. Toyama, T. Suppression of ING1 expression in sporadic breast cancer. Oncogene 18, 5187-5193 (1999).
65. Campos, E.I., Martinka, M., Mitchell, D.L., Dai, D.L., and Li, G. Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair. Int. J. Oncol. 25, 73-80 (2004).
66. Gunduz, M. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res. 60, 3143-3146 (2000).
67. Chen L, et al. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. Cancer Res. 61, 4345-4349 (2001).
68. Zhou, M.I., Wang, H., Foy, R.L., Ross, J.J., and Cohen, H.T. Tumor suppressor von Hippel-Lindau (VHL). stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent. Cancer Res. 64, 1278-1286 (2004).
69. Schwarz, K. RAG mutations in human B cell-negative SCID. Science 274, 97-99 (1996).
70. Gomez, C.A. Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D).J recombination and result in primary immunodeficiencies. Mol. Cell Biol. 20, 5653-5664 (2000).
71. Sobacchi, C., Marrella, V., Rucci, F., Vezzoni, P., and Villa, A. RAG-dependent primary immunodeficiencies. Hum. Mutat. 27, 1174-1184. (2006).
72. Noordzij, J.G. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins. Blood 100, 2145-2152 (2002).
73. Tzschach, A. Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. Hum. Mutat. 27, 389 (2006).
74. Sauer, A.V. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Blood 114, 3216-3226 (2009).
75. Unoki, M., Kumamoto, K., and Harris, C.C. ING proteins as potential anticancer drug targets. Curr. Drug Targets 10, 442-454 (2009).
76. Bronner, C. The UHRF family: Oncogenes that are drugable targets for cancer therapy in the near future? Pharm. Ther. 115, 419-434 (2007).